MedTrace Logo

Volume Kinetics of Gelofusine 4% During Vascular Surgery

NCT06474052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-06-25

No results posted yet for this study

Summary

The volume kinetics of the commercially available colloid fluid, Gelofusine 4%, have not been previously studied. Adult patients undergoing open vascular surgery, including femoral and carotid endarterectomy as well as bypass surgery, received general anesthesia. Following the induction of anesthesia, Gelofusine 4% was administered at a dosage of 10 ml/kg over a 30-minute period. Hemoglobin concentration was monitored for up to 180 minutes post-administration to construct a plasma hemodilution profile.

Conditions

  • Fluid Electrolyte Disorders

Interventions

DRUG

Gelofusine 4%

Gelofusine 4% 10 ml/kg is administered following anaesthesia induction in 30 minutes.

Sponsors & Collaborators

  • Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

    lead OTHER

Principal Investigators

  • Robert Hahn, Professor · Karolinska Institutet: Stockholm, SE (Department of Clinical Sciences, Danderyd Hospital) Employment

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-03-31
Completion
2024-04-15
FDA Drug
Yes

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06474052 on ClinicalTrials.gov